Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism

Andrologia

Volumn 43, Issue 1, 2011, Pages 52-56

  Yamaguchi, K ^a   Ishikawa, T ^a   Chiba, K ^a   Fujisawa, M ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ageing men; Androgen therapy; LOH; Testosterone.

Indexed keywords

ALANINE AMINOTRANSFERASE; ANDROGEN; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE; TESTOSTERONE ENANTATE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AGEING MALE SYMPTOM SCALE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANDROGEN BLOOD LEVEL; ANDROGEN DECLINE IN THE AGEING MALE QUESTIONNAIRE; ANDROGEN THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; ERYTHROCYTE COUNT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; LATE ONSET HYPOGONADISM; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGE OF ONSET; AGED; ERYTHROCYTE COUNT; HEALTH SURVEYS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LIPID METABOLISM; LIVER; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; RETROSPECTIVE STUDIES; TESTOSTERONE; TREATMENT OUTCOME;

EID: 78651231885     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2009.01015.x     Document Type: Article

References (26)

1. Barrett-Connor E, Khaw KT (1988) Endogenous sex hormones and cardiovascular disease in men: a prospective population-based study. Circulation 78:539-545.
2. Cauley JA, Gutai JP, Kuller LH, Dai WS (1987) Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol 60:771-777.
3. Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G (2004) Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 63:641-646.
4. Contoreggi CS, Blackman MR, Andres R, Muller DC, Lakatta EG, Felg JL, Harman SM (1990) Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men. J Androl 11:460-470.
5. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87:589-598.
6. Härkönen K, Huhtaniemi I, Mäkinen J, Hübler D, Irjala K, Koskenvuo M, Oettel M, Raitakari O, Saad F, Pöllänen P (2003) The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26:187-194.
7. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W (1999) A new 'aging male's symptoms' rating scale. Aging Male 2:105-114.
8. Huhtaniemi I, Mäkinen JI, Perheentupa A, Raitakari OT (2008) Late-onset hypogonadism in men. Experience from the Turku Male Ageing Study (TuMAS). Hormones (Athens) 7:36-45.
9. Ishikawa T, Yamaguchi K, Kondo Y, Takenaka A, Fujisawa M (2008) Metabolic syndrome in men with Klinefelter's syndrome. Urology 71:1109-1113.
10. Iwamoto T, Yanase T, Koh E, Hitoshi Horie, Katsuyuki Baba, Mikio Namiki, Hajime Nawata (2004) Reference ranges of total serum and free testosterone in Japanese male adults. Nippon Hinyokika Gakkai Zasshi. 95:751-760.
11. Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876.
12. Kawa G, Taniguchi H, Kinoshita H, Matsuda T, Urakami M, Sawaragi I (2008) Aging male symptoms and serum testosterone levels in healthy Japanese middle-aged men. Nippon Hinyokika Gakkai Zasshi 99:645-651.
13. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116:2694-2701.
14. Lunenfeld B, Saad F, Hoesl CE (2005) ISA, ISSAM and EAU recommendation for investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationale. Aging Male 8:59-74.
15. Mäkinen J, Järvisalo MJ, Pöllänen P, Perheentupa A, Irjala K, Koskenvuo M, Mäkinen J, Huhtaniemi I, Raitakari OT (2005) Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45:1603-1608.
16. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB (2005) Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 62:64-73.
17. Morales A, Lunenfeld B, International Society for the Study of the Aging Male. (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 5:74-86.
18. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry HM III (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49:1239-1242.
19. Namiki M, Akaza H, Shimazui T, Ito N, Iwamoto T, Baba K, Kumano H, Koh E, Tsujimura A, Matsumiya K, Horie S, Maruyama O, Marumo K, Yanase T, Kumamoto Y (2008) Clinical practice manual for late-onset hypogonadism syndrome. Int J Urol 15:377-388.
20. Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings S (2006) Testosterone and estradiol among older men. J Clin Endocrinol Metab 91:1336-1344.
21. Rhoden EL, Morgentaler A (2004) Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350:482-492.
22. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653.
23. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92:549-555.
24. Westaby D, Ogle SJ, Paradinas FJ, Randell JB, Murray-Lyon IM (1977) Liver damage from long-term methyltestosterone. Lancet 2:262-263.
25. Wu FC, von Eckardstein A (2003) Androgens and coronary artery disease. Endocr Re 24:183-217.
26. Zitzmann M, Faber S, Nieschlag E (2006) Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335-4343.